oxycodone and Cancer-Associated Pain

oxycodone has been researched along with Cancer-Associated Pain in 66 studies

Research

Studies (66)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	42 (63.64)	24.3611
2020's	24 (36.36)	2.80

Authors

Authors	Studies
Kuroki, A; Shirota, M; Takagi, S; Yasu, T	1
Coulter, P; Fallon, M; Hughes, LT; Laird, B; Raftery, D	1
Matsuda, Y; Niki, K; Okamoto, Y; Omae, T; Takagi, T; Takemura, M; Ueda, M	1
Arnold, S; Bennett, MI; Bromham, N; Chi, Y; Hilgart, JS; Page, AJ; Schmidt-Hansen, M	1
Barrachina, J; Inda, MD; López-Gil, S; López-Gil, V; Margarit, C; Morales, D; Muriel, J; Peiró, AM; Planelles, B; Vara-González, A	1
Chen, DD; Chen, HZ; Cheng, TF; Cui, BX; Dai, XJ; Hou, XB; Wang, D; Wang, Y; Wang, YY; Xu, H	1
Adile, C; Cascio, AL; Casuccio, A; Ferrera, P; Mercadante, S	1
Chiba, Y; Fujita, Y; Haratani, K; Hayashi, H; Koyama, A; Makimura, C; Matsuoka, H; Nakagawa, K; Nakura, M; Nishio, K; Ohtake, Y; Okuno, T; Sakai, K; Sakamoto, R; Takeda, M; Takegawa, N; Tanaka, K; Tsurutani, J; Yoshida, T	1
Figg, WD; Smith, DM	1
Boland, JW	1
Dräger, DL	1
Fujimoto, H; Funato, M; Kawana, M; Kiribayashi, M; Kokubun, H; Kondo, M; Kusakabe, A; Miyasato, A; Nagatani, K; Nakamura, K; Ohno, R; Okamoto, K; Onoda, C; Ozeki, A; Suzuki, N	1
Arakawa, S; Chiu, SW; Hiratsuka, Y; Hirayama, H; Inoue, A; Ishiki, H; Kosugi, K; Kubo, E; Matsuda, Y; Miyashita, M; Morita, T; Natsume, M; Nishijima, K; Ouchi, K; Sato, M; Satomi, E; Shigeno, T; Shimizu, M; Shimoda, M; Shimoi, T; Tagami, K; Yamaguchi, T; Yokomichi, N	1
Bao, T; Chittams, J; Mao, JJ; Meghani, SH; Rosa, WE; Vallerand, AH	1
Ashizawa, K; Hara, T; Ikeda, T; Ishii, K; Kamada, M; Komatsu, Y; Matsuo, K; Morishita, S; Ryu, E; Yamaguchi, M; Yamashita, H	1
Kasahara, Y; Morikawa, N; Nishihara, M; Nishikura, K; Takahashi, Y	1
Deng, HS; He, QL; Li, HB; Ni, HD; Wang, YG; Xu, LS; Xu, M; Yao, M	1
Lei, F; Wang, J; Xia, Z; Ye, J	1
Lin, R; Xu, C; Zhao, S	1
Jiang, G; Wang, Y; Zhou, J	1
Watanabe, K	1
Chen, L; Chen, Z; Deng, Y; Feng, W; Li, L; Liang, J; Tang, Y; Xian, H; Yang, S; Zhang, H; Zhang, S	1
Huang, HX; Huang, YM; Liu, KK; Liu, WH; Xiao, J; Zhang, L	1
Aggarwal, G; Ahmedzai, S; Douglas, C; Green, M; Le, BH; Nicoll, A	1
Imai, S; Kato, S; Koyanagi, R; Kumai, M; Sugawara, M; Takekuma, Y; Tsuruga, K; Yamada, T	1
Dong, S; Dou, Z; Knaggs, R; Li, Y; Lu, G; Ma, J; Xia, J; Yang, L; Zhao, S	1
Amato, F; Ceniti, S; Consoletti, L; Magaldi, D; Mameli, S; Marcassa, C; Notaro, P; Palmieri, V; Pisanu, GM; Vellucci, R	1
Kaye, AD; Mancuso, KF; Ruan, X	1
Tormey, WP	1
Bell, RF; Derry, S; Moore, RA; Wee, B; Wiffen, PJ	1
Azhar, A; Baumgartner, K; Bruera, E; Dost, S; Heung, Y; Kwan, S; Lim, KH; Liu, D; Nguyen, A; Pangemanan, I; Reddy, A; Rodriguez, E; Stephen, S; Tayjasanant, S; Vidal, M; Waletich, J; Williams, J; Wong, A; Wu, J; Yennurajalingam, S	1
Benevento, F; Bolondi, L; Brandi, G; De Lorenzo, S; Piscaglia, F; Samolsky Dekel, BG; Tovoli, F	1
Arnold, S; Bennett, MI; Bromham, N; Hilgart, JS; Schmidt-Hansen, M	2
Leppert, W; Nosek, H; Nosek, K; Onichimowski, D; Wordliczek, J	1
Ahn, JS; Eum, YJ; Hong, YS; Kang, JH; Kim, JE; Kim, JS; Kim, MK; Kim, SY; Kim, TW; Koh, SA; Lee, GW; Lee, KH; Yun, HJ	1
Chiba, Y; Fujita, Y; Koyama, A; Matsuoka, H; Nakagawa, K; Nishio, K; Otake, Y; Sakai, K; Terashima, M; Tsurutani, J; Yoshida, T	1
Ando, M; Ando, Y; Gyawali, B; Hasegawa, Y; Kato, H; Kondo, M; Kubo, Y; Miyazaki, M; Morita, T; Murasaki, Y; Sugishita, M; Tsukuura, H; Yamada, K	1
Hori, Y; Matsuda, S; Okamoto, T; Sakamoto, A; Shimizu, A; Yamashita, M	1
Cavalloro, F; Ciuffreda, A; Ilardi, M; Marino, E; Piloni, D; Spiaggi, E; Stella, GM	1
Chen, Y; Hu, L; Li, J; Mei, Q; Peng, P; Tian, Y; Xia, S	1
Hojo, M; Kokubun, H; Matoba, M; Ryu, E; Tomiyasu, S; Yoshimoto, T	1
Bayer, O; Heid, F; Laufenberg-Feldmann, R; Schuster, M	1
Aruga, E; Inoue, S; Saito, Y; Takahashi, H; Tsuneto, S; Uemori, M	1
Choi, MK; Eum, YJ; Kang, JH; Lee, KH; Oh, HS; Park, HJ; Shim, BY	1
Feng, Z; Guo, J; Guo, X; Peng, Z; Zhang, Y	1
Song, Z; Wang, W; Zhang, Y	1
Deng, CQ; Guo, KK; Lu, GJ; Zhao, GL	1
Ammar, D; Baron, L; Chvetzoff, G; Collin, E; Delorme, C; Delorme, T; Faure, S; Filbet, M; Hubault, P; Jovenin, N; Krakowski, I; Magnet, M; Michenot, N; Minello, C; Poulain, P; Rostaing, S	1
Bechakra, M; Jongen, JLM; Koch, BCP; Moerdijk, F; Sillevis Smitt, PAE; van der Rijt, CCD; van Rosmalen, J	1
Bie, M; Li, X; Lin, T; Song, J; Zhang, C	1
Cai, Y; Chen, L; Fan, Y; Guo, L; Hu, W; Hua, X; Wang, C	1
Deng, HS; Liu, MJ; Ni, HD; Pan, H; Shen, H; Wang, TT; Xu, LS; Yang, MX; Yao, M	1
Alarcón, MDL; Cabezón-Gutiérrez, L; Estévez, FV; Jiménez-López, AJ; Martín-Arroyo, JMT; Padrós, MC; Rebollo, MA; Sanz-Yagüe, A	1
Brás, M; Fragoso, M; Vieira, C	1
Guo, Q; Han, F; Lu, L; Pan, H; Pan, J; Qian, S; Shen, P; Shu, Q; Wang, K; Xu, Q; Yang, Z; Zhang, P; Zhou, Y	1
Leppert, W; Nosek, K	1
Dasgupta, N; Jonsson Funk, M; Young, JC	1
Chisaki, Y; Fujihara, S; Matsumura, C; Takahashi, K; Yamada, M; Yano, Y	1
Apolone, G; Azzarello, G; Bandieri, E; Caraceni, A; Cavanna, L; Corli, O; Crispino, C; Di Gregorio, R; Dragani, TA; Floriani, I; Galli, F; Gamucci, T; Greco, MT; Iorno, V; Kaasa, S; Lipari, G; Luzzani, M; Montanari, M; Pacchioni, M; Pavesi, L; Reale, C; Roberto, A; Valenti, D	1
Ishikawa, H; Matsumoto, T; Mori, K; Omae, K; Osaka, I; Sato, T; Shino, M; Tanaka, R	1
Choy, LW; Ismail, CR; Rahman, NA; Zin, CS	1
Alabiso, O; Biancofiore, G; Bortolussi, R; Bracchi, P; Brunelli, C; Caraceni, A; Colonna, U; De Sangro, C; Ferrari, V; Finco, G; Kaasa, S; Maltoni, M; Montanari, L; Moro, C; Rosti, G; Roy, MT; Zecca, E	1
Chen, DL; Li, YH; Wang, ZJ; Zhu, YK	1
Boyle, F; Franklin, AE; Lovell, MR	1
Aoyama, Y; Nawa, T; Okawa, M; Onodera, Y; Saito, Y; Shimizu, K; Yamamoto, M; Yamamoto, Y	1

Reviews

16 review(s) available for oxycodone and Cancer-Associated Pain

Article	Year
Use of opioids in patients with cancer with hepatic impairment-a systematic review. BMJ supportive & palliative care, 2022, Volume: 12, Issue:2 Topics: Adolescent; Analgesics, Opioid; Cancer Pain; Humans; Morphine; Neoplasms; Oxycodone	2022
Oxycodone for cancer-related pain. The Cochrane database of systematic reviews, 2022, 06-09, Volume: 6 Topics: Adult; Analgesics, Opioid; Cancer Pain; Constipation; Humans; Morphine; Nausea; Neoplasms; Oxycodone; Pain; Quality of Life; Reproducibility of Results; Sleepiness; Vomiting	2022
Meta-analysis of efficacy and safety of sustained release oxycodone hydrochloride rectal administration for moderate to severe pain. PloS one, 2022, Volume: 17, Issue:6 Topics: Administration, Rectal; Cancer Pain; Delayed-Action Preparations; Humans; Oxycodone; Pain	2022
Tapentadol for the management of cancer pain in adults: an update. Current opinion in supportive and palliative care, 2023, 06-01, Volume: 17, Issue:2 Topics: Adult; Analgesics; Analgesics, Opioid; Cancer Pain; Humans; Morphine; Multicenter Studies as Topic; Neoplasms; Oxycodone; Pain; Phenols; Quality of Life; Randomized Controlled Trials as Topic; Receptors, Opioid; Tapentadol	2023
A Bibliometric Analysis of Publications on Oxycodone from 1998 to 2017. BioMed research international, 2019, Volume: 2019 Topics: Analgesics, Opioid; Bibliometrics; Cancer Pain; Humans; Neuralgia; Oxycodone; Publications	2019
Oxycodone versus morphine for cancer pain titration: A systematic review and pharmacoeconomic evaluation. PloS one, 2020, Volume: 15, Issue:4 Topics: Cancer Pain; Cost-Benefit Analysis; Decision Trees; Delayed-Action Preparations; Economics, Pharmaceutical; Humans; Morphine; Oxycodone; Publication Bias; Risk; Treatment Outcome	2020
Oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe, chronic cancer pain: Challenges in the context of hepatic impairment. Asia-Pacific journal of clinical oncology, 2022, Volume: 18, Issue:1 Topics: Analgesics, Opioid; Cancer Pain; Constipation; Delayed-Action Preparations; Humans; Liver Diseases; Naloxone; Neoplasms; Oxycodone; Tablets	2022
Hydromorphone for cancer pain. The Cochrane database of systematic reviews, 2021, 08-05, Volume: 8 Topics: Adult; Analgesics, Opioid; Cancer Pain; Child; Humans; Hydromorphone; Male; Middle Aged; Morphine; Neoplasms; Oxycodone	2021
Revisiting Oxycodone Analgesia: A Review and Hypothesis. Anesthesiology clinics, 2017, Volume: 35, Issue:2 Topics: Abdominal Pain; Analgesia; Analgesia, Patient-Controlled; Analgesics, Opioid; Cancer Pain; Humans; Morphine; Oxycodone; Pain; Pain Measurement	2017
Opioids for cancer pain - an overview of Cochrane reviews. The Cochrane database of systematic reviews, 2017, 07-06, Volume: 7 Topics: Acetaminophen; Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Buprenorphine; Cancer Pain; Codeine; Fentanyl; Humans; Hydromorphone; Methadone; Oxycodone; Phenols; Review Literature as Topic; Tapentadol; Tramadol	2017
Oxycodone for cancer-related pain. The Cochrane database of systematic reviews, 2017, 08-22, Volume: 8 Topics: Aged; Analgesics, Opioid; Cancer Pain; Constipation; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Morphine; Nausea; Neoplasms; Oxycodone; Pain Measurement; Quality of Life; Randomized Controlled Trials as Topic; Sleep Stages; Vomiting	2017
Efficacy, tolerability and acceptability of oxycodone for cancer-related pain in adults: an updated Cochrane systematic review. BMJ supportive & palliative care, 2018, Volume: 8, Issue:2 Topics: Analgesics, Opioid; Cancer Pain; Humans; Oxycodone; Pain Management; Patient Preference; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome	2018
Opioid Rotation in Cancer Pain Treatment. Deutsches Arzteblatt international, 2018, 03-02, Volume: 115, Issue:9 Topics: Analgesics, Opioid; Buprenorphine; Cancer Pain; Chronic Pain; Fentanyl; Germany; Humans; Hydromorphone; Morphine; Neoplasms; Oxycodone; Pain Management	2018
Comparison of analgesic effect of oxycodone and morphine on patients with moderate and advanced cancer pain: a meta-analysis. BMC anesthesiology, 2018, 09-24, Volume: 18, Issue:1 Topics: Analgesics, Opioid; Cancer Pain; Humans; Morphine; Oxycodone; Randomized Controlled Trials as Topic; Treatment Outcome	2018
[Opioid switch and change of route of administration in cancer patients treated by morphine]. Bulletin du cancer, 2018, Volume: 105, Issue:11 Topics: Administration, Oral; Analgesics, Opioid; Breakthrough Pain; Cancer Pain; Drug Substitution; Fentanyl; France; Humans; Hydromorphone; Injections, Intravenous; Injections, Subcutaneous; Methadone; Morphine; Oxycodone; Phenols; Tapentadol	2018
[Opioids for Cancer Pain and its Use under Particular Conditions: A Narrative Review]. Acta medica portuguesa, 2019, May-31, Volume: 32, Issue:5 Topics: Administration, Oral; Analgesics, Opioid; Buprenorphine; Cancer Pain; Codeine; Deglutition Disorders; Fentanyl; Humans; Hydromorphone; Liver Failure; Morphine; Oxycodone; Renal Dialysis; Renal Insufficiency; Tapentadol; Tramadol	2019

Trials

16 trial(s) available for oxycodone and Cancer-Associated Pain

Article	Year
Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study). The oncologist, 2023, 03-17, Volume: 28, Issue:3 Topics: Analgesics, Opioid; Biomarkers; Cancer Pain; Catechol O-Methyltransferase; Genotype; Humans; Morphine; Neoplasms; Oxycodone; Pain	2023
Controlled Release of Oxycodone as an Opioid Titration for Cancer Pain Relief: A Retrospective Study. Medical science monitor : international medical journal of experimental and clinical research, 2020, Mar-18, Volume: 26 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Constipation; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Oxycodone; Pain Management; Pain Measurement; Retrospective Studies; Sleepiness; Treatment Outcome; Vomiting; Xerostomia; Young Adult	2020
A 12-hour rapid titration method for cancer pain: a randomized, controlled, open-label study. Annals of palliative medicine, 2021, Volume: 10, Issue:1 Topics: Analgesics, Opioid; Cancer Pain; Humans; Morphine; Neoplasms; Oxycodone; Quality of Life	2021
High dosage of a fixed combination oxycodone/naloxone prolonged release: efficacy and tolerability in patients with chronic cancer pain. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Analgesics; Breakthrough Pain; Cancer Pain; Chronic Pain; Constipation; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Laxatives; Male; Middle Aged; Naloxone; Neoplasms; Oxycodone; Pain Management; Pain Measurement; Quality of Life	2017
A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients. Drug design, development and therapy, 2017, Volume: 11 Topics: Administration, Cutaneous; Administration, Oral; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Cancer Pain; Constipation; Delayed-Action Preparations; Drug Therapy, Combination; Fentanyl; Humans; Lactulose; Male; Middle Aged; Morphine; Oxycodone; Pain Measurement; Severity of Illness Index	2017
Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial. Chinese journal of cancer, 2017, Sep-11, Volume: 36, Issue:1 Topics: Adult; Cancer Pain; Female; Humans; Korea; Male; Naloxone; Oxycodone; Quality of Life; Young Adult	2017
Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study). BMC cancer, 2017, Oct-06, Volume: 17, Issue:1 Topics: Analgesics, Opioid; Biomarkers, Tumor; Cancer Pain; Catechol O-Methyltransferase; Female; Humans; Male; Morphine; Neoplasms; Oxycodone; Pain Management; Polymorphism, Single Nucleotide	2017
Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial. The oncologist, 2018, Volume: 23, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antiemetics; Cancer Pain; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Oxycodone; Prochlorperazine; Treatment Failure; Vomiting	2018
Efficacy and Safety of Oxycodone Injection for Relieving Cancer Pain: A Study in Japan Consisting of Two Open Trials for Intravenous and Subcutaneous Administration. Biological & pharmaceutical bulletin, 2018, Jun-01, Volume: 41, Issue:6 Topics: Aged; Analgesics, Opioid; Cancer Pain; Female; Humans; Injections, Intravenous; Injections, Subcutaneous; Japan; Male; Middle Aged; Oxycodone; Treatment Outcome	2018
A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients. Japanese journal of clinical oncology, 2018, Jun-01, Volume: 48, Issue:6 Topics: Aged; Analgesics, Opioid; Asian People; Cancer Pain; Delayed-Action Preparations; Demography; Depression; Double-Blind Method; Female; Humans; Hydromorphone; Japan; Male; Neoplasms; Oxycodone; Pain Measurement; Powders; Tablets; Treatment Outcome	2018
Intravenous Oxycodone versus Intravenous Morphine in Cancer Pain: A Randomized, Open-Label, Parallel-Group, Active-Control Study. Pain research & management, 2017, Volume: 2017 Topics: Administration, Intravenous; Adult; Age Distribution; Aged; Analgesics, Opioid; Cancer Pain; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Morphine; Oxycodone; Pain Measurement; Patient Satisfaction; Republic of Korea; Retrospective Studies; Young Adult	2017
Efficacy and safety of sustained-release oxycodone compared with immediate-release morphine for pain titration in cancer patients: A multicenter, open-label, randomized controlled trial (SOCIAL). Medicine, 2019, Volume: 98, Issue:24 Topics: Aged; Cancer Pain; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Morphine; Oxycodone; Pain Measurement; Treatment Outcome	2019
Comparison of the Quality of Life of Cancer Patients with Pain Treated with Oral Controlled-Release Morphine and Oxycodone and Transdermal Buprenorphine and Fentanyl. Current pharmaceutical design, 2019, Volume: 25, Issue:30 Topics: Analgesics, Opioid; Buprenorphine; Cancer Pain; Delayed-Action Preparations; Female; Fentanyl; Humans; Male; Morphine; Neoplasms; Oxycodone; Quality of Life	2019
Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids. Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:6 Topics: Adult; Aged; Analgesics, Opioid; Cancer Pain; Drug-Related Side Effects and Adverse Reactions; Female; Fentanyl; Humans; Male; Middle Aged; Morphine; Neoplasms; Oxycodone	2016
Comparison of the Tolerability Profile of Controlled-Release Oral Morphine and Oxycodone for Cancer Pain Treatment. An Open-Label Randomized Controlled Trial. Journal of pain and symptom management, 2016, Volume: 52, Issue:6 Topics: Adult; Aged; Analgesics, Opioid; Cancer Pain; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Morphine; Oxycodone; Pain Measurement; Palliative Care; Risk; Treatment Outcome	2016
The research on long-term clinical effects and patients' satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain. Medicine, 2016, Volume: 95, Issue:42 Topics: Adult; Amines; Analgesics; Cancer Pain; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Narcotics; Oxycodone; Pain Measurement; Patient Satisfaction; Prospective Studies; Severity of Illness Index; Treatment Outcome	2016

Other Studies

34 other study(ies) available for oxycodone and Cancer-Associated Pain

Article	Year
Drug-Drug Interactions Associated with Introduction of Oxycodone for Management of Cancer-Related Pain in Hospitalized Patients. Journal of palliative medicine, 2021, Volume: 24, Issue:9 Topics: Analgesics, Opioid; Cancer Pain; Delayed-Action Preparations; Drug Interactions; Humans; Neoplasms; Oxycodone; Pharmaceutical Preparations	2021
Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone. Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Dose-Response Relationship, Drug; Female; Fentanyl; Humans; Hydromorphone; Japan; Male; Methadone; Middle Aged; Neoplasms; Neuralgia; Oxycodone; Pain Measurement; Retrospective Studies; Tapentadol	2021
Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study. Scientific reports, 2022, 06-16, Volume: 12, Issue:1 Topics: Analgesics, Opioid; Cancer Pain; Chronic Pain; Constipation; Delayed-Action Preparations; Drug Combinations; Female; Humans; Morphine; Naloxone; Oxycodone; Pharmacogenomic Testing; Quality of Life; Tapentadol	2022
Rapid Titration With Intravenous Oxycodone for Severe Cancer Pain and Oral Conversion Ratio. Journal of pain and symptom management, 2022, Volume: 64, Issue:6 Topics: Analgesics, Opioid; Cancer Pain; Humans; Neoplasms; Oxycodone; Pain	2022
Evidence Regarding Pharmacogenetics in Pain Management and Cancer. The oncologist, 2023, 03-17, Volume: 28, Issue:3 Topics: Analgesics, Opioid; Cancer Pain; Catechol O-Methyltransferase; Cytochrome P-450 CYP2D6; Genotype; Humans; Morphine; Neoplasms; Oxycodone; Pain Management; Pharmacogenetics	2023
[Drug therapy for cancer-related pain-evidence regarding hydromorphone, oxycodone, and methadone : Presentation and summary of three Cochrane reviews]. Urologie (Heidelberg, Germany), 2023, Volume: 62, Issue:6 Topics: Analgesics, Opioid; Cancer Pain; Humans; Hydromorphone; Methadone; Neoplasms; Oxycodone	2023
Comparison of Analgesic Efficacy and Safety of Low-Dose Transdermal Fentanyl and Oral Oxycodone in Opioid-Naïve Patients with Cancer Pain. Biological & pharmaceutical bulletin, 2023, Volume: 46, Issue:10 Topics: Administration, Cutaneous; Analgesics; Analgesics, Opioid; Cancer Pain; Fentanyl; Humans; Neoplasms; Oxycodone	2023
Prevalence of opioid-induced adverse events across opioids commonly used for analgesic treatment in Japan: a multicenter prospective longitudinal study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2023, Oct-16, Volume: 31, Issue:12 Topics: Analgesics, Opioid; Cancer Pain; Constipation; Delirium; Fentanyl; Humans; Hydromorphone; Japan; Longitudinal Studies; Nausea; Oxycodone; Prevalence; Prospective Studies; Tramadol; Vomiting	2023
Both Race and Insurance Type Independently Predict the Selection of Oral Opioids Prescribed to Cancer Outpatients. Pain management nursing : official journal of the American Society of Pain Management Nurses, 2020, Volume: 21, Issue:1 Topics: Administration, Oral; Adult; Aged; Analgesics, Opioid; Cancer Pain; Female; Humans; Insurance Coverage; Logistic Models; Male; Middle Aged; Morphine; Neoplasms; Outpatients; Oxycodone; Racial Groups	2020
Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis. Internal medicine (Tokyo, Japan), 2020, Jan-15, Volume: 59, Issue:2 Topics: Analgesics, Opioid; Breast Neoplasms; Cancer Pain; Female; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Induced Constipation; Oxycodone; Substance Withdrawal Syndrome	2020
Risk Factors for Poor Pain Control after Opioid Switching from Oxycodone Tablet to Fentanyl Patch. Biological & pharmaceutical bulletin, 2019, Volume: 42, Issue:10 Topics: Aged; Analgesics, Opioid; Cancer Pain; Dose-Response Relationship, Drug; Drug Interactions; Drug Substitution; Female; Fentanyl; Humans; Liver Neoplasms; Male; Middle Aged; Oxycodone; Pain Management; Protein Binding; Risk Factors; Tablets; Transdermal Patch	2019
Phosphoproteomic profiling of oxycodone‑treated spinal cord of rats with cancer‑induced bone pain. Molecular medicine reports, 2019, Volume: 20, Issue:5 Topics: Animals; Cancer Pain; Female; Neoplasm Proteins; Neoplasms, Experimental; Oxycodone; Phosphoproteins; Proteomics; Rats; Rats, Sprague-Dawley; Spinal Neoplasms	2019
[Analysis of Symptoms Relieved in Addition to Pain after Administration of Oxycodone or Morphine to Patients with Advanced Cancer Living at Home]. Gan to kagaku ryoho. Cancer & chemotherapy, 2020, Volume: 47, Issue:5 Topics: Administration, Cutaneous; Analgesics, Opioid; Cancer Pain; Fentanyl; Humans; Morphine; Neoplasms; Oxycodone; Pain	2020
Influencing factors of end-of-dose failure in patients with cancer pain after oral oxycodone sustained-release tablets: a retrospective, case-control study. Japanese journal of clinical oncology, 2021, May-28, Volume: 51, Issue:6 Topics: Administration, Oral; Cancer Pain; Case-Control Studies; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Oxycodone; Retrospective Studies; Tablets	2021
Construction of a Risk Prediction Model of Extended Release Oxycodone Tablet-Induced Nausea and Clarification of Predictive Factors. Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:4 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Decision Trees; Delayed-Action Preparations; Female; Humans; Logistic Models; Male; Middle Aged; Models, Theoretical; Nausea; Oxycodone; Retrospective Studies; Risk Factors; Sex Factors; Tablets; Young Adult	2021
Oxycodone in Palliative Care-Art and Empathy Still Have a Place. Journal of palliative care, 2017, Volume: 32, Issue:1 Topics: Analgesics, Opioid; Breast Neoplasms; Cancer Pain; Cause of Death; Coroners and Medical Examiners; Fatal Outcome; Female; Humans; Middle Aged; Oxycodone; Palliative Care; Poisoning; Suicide	2017
The Conversion Ratio From Intravenous Hydromorphone to Oral Opioids in Cancer Patients. Journal of pain and symptom management, 2017, Volume: 54, Issue:3 Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Drug Dosage Calculations; Female; Humans; Hydromorphone; Linear Models; Male; Middle Aged; Morphine; Oxycodone; Palliative Care; Patient Discharge; Retrospective Studies; Treatment Outcome; Young Adult	2017
Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver, 2018, Volume: 38, Issue:2 Topics: Administration, Oral; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Carcinoma, Hepatocellular; Chronic Pain; Delayed-Action Preparations; Drug Combinations; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Naloxone; Narcotic Antagonists; Oxycodone; Preliminary Data; Quality of Life; Treatment Outcome	2018
Oxycodone Resistance Due to Rifampin Use in an Osteosarcoma Patient with Tuberculosis. The American journal of case reports, 2017, Oct-24, Volume: 18 Topics: Adult; Analgesics, Opioid; Antibiotics, Antitubercular; Bone Neoplasms; Cancer Pain; Drug Resistance; Humans; Lung Neoplasms; Male; Osteosarcoma; Oxycodone; Rifampin; Tuberculosis, Pulmonary	2017
Prolonged-release oxycodone-naloxone for pain management in advanced EGFR wild-type lung cancer patients. Minerva medica, 2018, Volume: 109, Issue:4 Topics: Aged; Cancer Pain; Delayed-Action Preparations; Drug Combinations; ErbB Receptors; Female; Humans; Lung Neoplasms; Male; Naloxone; Oxycodone; Pain Management; Retrospective Studies	2018
The impact of UGT2B7 C802T and CYP3A41G polymorphisms on pain relief in cancer patients receiving oxycontin. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018, Volume: 26, Issue:8* Topics: Adult; Aged; Analgesics, Opioid; Cancer Pain; Cytochrome P-450 CYP3A; Female; Genotype; Glucuronosyltransferase; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Polymorphism, Single Nucleotide; Young Adult	2018
Patient-Controlled Intravenous Analgesia for Advanced Cancer Patients with Pain: A Retrospective Series Study. Pain research & management, 2018, Volume: 2018 Topics: Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Cancer Pain; Female; Humans; Hydromorphone; Male; Middle Aged; Oxycodone; Pain Management; Patient Satisfaction; Retrospective Studies; Sufentanil	2018
Efficacy and Safety of High-Dose Controlled-Release Oxycodone in the Treatment of Moderate to Severe Pain in Patients with Advanced Cancer: A Retrospective Study. Medical science monitor : international medical journal of experimental and clinical research, 2018, Sep-19, Volume: 24 Topics: Adult; Aged; Analgesics, Opioid; Cancer Pain; China; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Pain Measurement; Quality of Life; Retrospective Studies; Self Report; Treatment Outcome	2018
Opioid responsiveness of nociceptive versus mixed pain in clinical cancer patients. European journal of cancer (Oxford, England : 1990), 2018, Volume: 105 Topics: Aged; Analgesics; Analgesics, Opioid; Cancer Pain; Drug Therapy, Combination; Female; Fentanyl; Humans; Male; Middle Aged; Morphine; Neuralgia; Nociceptive Pain; Oxycodone; Pain Measurement; Prospective Studies	2018
[Relationship of OPRM1 118A/G gene polymorphism and oxycodone analygesic dose in paitents with cancer pain]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2018, Dec-10, Volume: 35, Issue:6 Topics: Analgesics, Opioid; Cancer Pain; Dose-Response Relationship, Drug; Genotype; Humans; Oxycodone; Polymorphism, Single Nucleotide; Receptors, Opioid, mu	2018
Standardized nursing and therapeutic effect of oxycontin on oral mucosal pain in nasopharyngeal carcinoma patients. Journal of cancer research and therapeutics, 2018, Volume: 14, Issue:7 Topics: Adult; Aged; Analgesics, Opioid; Cancer Pain; Female; Humans; Male; Middle Aged; Mouth Mucosa; Nasopharyngeal Carcinoma; Nursing Care; Oxycodone; Pain Management; Pain Measurement; Patient Compliance; Psychotherapy; Quality of Life; Weight Loss; Young Adult	2018
Proteomic profiling reveals Arl6ip-1 as a candidate target in cancer-induced bone pain rat model after oxycodone treatment. Neuroscience letters, 2019, 04-23, Volume: 699 Topics: Adaptor Proteins, Signal Transducing; Animals; Astrocytes; Bone Neoplasms; Cancer Pain; Female; Membrane Proteins; Microglia; Oxycodone; Pain Measurement; Posterior Horn Cells; Proteomics; Rats	2019
Expert consensus on the management of breakthrough cancer pain in older patients. A Delphi study. Journal of geriatric oncology, 2019, Volume: 10, Issue:4 Topics: Administration, Mucosal; Aged; Analgesics, Opioid; Breakthrough Pain; Cancer Pain; Central Nervous System Depressants; Cytochrome P-450 Enzyme Inducers; Cytochrome P-450 Enzyme Inhibitors; Decision Making, Shared; Delphi Technique; Drug Interactions; Fentanyl; Frailty; Geriatric Assessment; Geriatrics; Humans; Medical Oncology; Morphine; Oxycodone; Pain Management; Pain Measurement; Palliative Medicine; Patient Care Team; Practice Guidelines as Topic	2019
Medical Use of Long-term Extended-release Opioid Analgesics in Commercially Insured Adults in the United States. Pain medicine (Malden, Mass.), 2020, 04-01, Volume: 21, Issue:4 Topics: Adult; Aged; Analgesics, Opioid; Arthritis; Back Pain; Cancer Pain; Chronic Pain; Delayed-Action Preparations; Duration of Therapy; Female; Fentanyl; Humans; Insurance, Health; Male; Middle Aged; Morphine; Oxycodone; Tramadol; United States	2020
Indication of Adequate Transdermal Fentanyl Dose in Opioid Switching From Oral Oxycodone in Patients With Cancer. The American journal of hospice & palliative care, 2016, Volume: 33, Issue:2 Topics: Administration, Cutaneous; Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Analgesics, Opioid; Body Mass Index; Cancer Pain; Dose-Response Relationship, Drug; Drug Dosage Calculations; Female; Fentanyl; Humans; Male; Middle Aged; Oxycodone; Pain Management; Pain Measurement; Regression Analysis; Retrospective Studies; Sex Factors	2016
Incidence of Delirium Among Patients Having Cancer Injected With Different Opioids for the First Time. The American journal of hospice & palliative care, 2017, Volume: 34, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Delirium; Drug-Related Side Effects and Adverse Reactions; Female; Fentanyl; Humans; Incidence; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Palliative Care	2017
Dose and Duration of Opioid Use in Patients with Cancer and Noncancer Pain at an Outpatient Hospital Setting in Malaysia. Pain practice : the official journal of World Institute of Pain, 2017, Volume: 17, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fentanyl; Humans; Malaysia; Male; Middle Aged; Morphine; Neoplasms; Outpatient Clinics, Hospital; Oxycodone; Pain; Retrospective Studies; Young Adult	2017
A Case of Opioid Toxicity on Conversion From Extended-Release Oxycodone and Naloxone to Extended-Release Oxycodone in a Patient With Liver Dysfunction. Journal of pain and symptom management, 2017, Volume: 53, Issue:2 Topics: Aged; Analgesics, Opioid; Cancer Pain; Carcinoma, Ductal; Delayed-Action Preparations; Drug Combinations; Drug Substitution; Female; Humans; Liver Diseases; Naloxone; Oxycodone	2017
[Outcomes of an Independent Clinical Study to Compare Branded and Generic Formulations of Sustained-Release Oxycodone]. Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:3 Topics: Aged; Bone Neoplasms; Cancer Pain; Drugs, Generic; Female; Humans; Lung Neoplasms; Male; Middle Aged; Oxycodone; Treatment Outcome	2017